Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction

Open access
de Boer, Rudolf A., Nayor, Matthew, deFilippi, Christopher R., Enserro, Danielle, Bhambhani, Vijeta, Kizer, Jorge R., Blaha, Michael J., Brouwers, Frank P., Cushman, Mary, Lima, Joao A. C., Bahrami, Hossein, van der Harst, Pim, Wang, Thomas J., Gansevoort, Ron T., Fox, Caroline S., Gaggin, Hanna K, Kop, Willem J., Liu, Kiang, Vasan, Ramachandran S., Psaty, Bruce M., Lee, Douglas S., Hillege, Hans L., Bartz, Traci M., Benjamin, Emelia J., Chan, Cheeling, Allison, Matthew, Gardin, Julius M., Januzzi, James L., Shah, Sanjiv J., Levy, Daniel, Herrington, David M., Larson, Martin G., van Gilst, Wiek H., Gottdiener, John S., Bertoni, Alain G., Ho, Jennifer E. · 2018 · JAMA Cardiology

Abstract

Importance: Nearly half of all patients with heart failure have preserved ejection fraction (HFpEF) as opposed to reduced ejection fraction (HFrEF), yet associations of biomarkers with future heart failure subtype are incompletely understood. Objective: To evaluate the associations of 12 cardiovascular biomarkers with incident HFpEF vs HFrEF among adults from the general population. Design, Setting, and Participants: This study included 4 longitudinal community-based cohorts: the Cardiovascular Health Study (1989-1990; 1992-1993 for supplemental African-American cohort), the Framingham Heart Study (1995-1998), the Multi-Ethnic Study of Atherosclerosis (2000-2002), and the Prevention of Renal and Vascular End-stage Disease study (1997-1998). Each cohort had prospective ascertainment of incident HFpEF and HFrEF. Data analysis was performed from June 25, 2015, to November 9, 2017. Exposures: The following biomarkers were examined: N-terminal pro B-type natriuretic peptide or brain natriuretic peptide, high-sensitivity troponin T or I, C-reactive protein (CRP), urinary albumin to creatinine ratio (UACR), renin to aldosterone ratio, D-dimer, fibrinogen, soluble suppressor of tumorigenicity, galectin-3, cystatin C, plasminogen activator inhibitor 1, and interleukin 6. Main Outcomes and Measures: Development of incident HFpEF and incident HFrEF. Results: Among the 22 756 participants in these 4 cohorts (12 087 women and 10 669 men; mean [SD] age, 60 [13] years) in the study, during a median follow-up of 12 years, 633 participants developed incident HFpEF, and 841 developed HFrEF. In models adjusted for clinical risk factors of heart failure, 2 biomarkers were significantly associated with incident HFpEF: UACR (hazard ratio [HR], 1.33; 95% CI, 1.20-1.48; P < .001) and natriuretic peptides (HR, 1.27; 95% CI, 1.16-1.40; P < .001), with suggestive associations for high-sensitivity troponin (HR, 1.11; 95% CI, 1.03-1.19; P = .008), plasminogen activator inhibitor 1 (HR, 1.22; 95% CI, 1.03-1.45; P = .02), and fibrinogen (HR, 1.12; 95% CI, 1.03-1.22; P = .01). By contrast, 6 biomarkers were associated with incident HFrEF: natriuretic peptides (HR, 1.54; 95% CI, 1.41-1.68; P < .001), UACR (HR, 1.21; 95% CI, 1.11-1.32; P < .001), high-sensitivity troponin (HR, 1.37; 95% CI, 1.29-1.46; P < .001), cystatin C (HR, 1.19; 95% CI, 1.11-1.27; P < .001), D-dimer (HR, 1.22; 95% CI, 1.11-1.35; P < .001), and CRP (HR, 1.19; 95% CI, 1.11-1.28; P < .001). When directly compared, natriuretic peptides, high-sensitivity troponin, and CRP were more strongly associated with HFrEF compared with HFpEF. Conclusions and Relevance: Biomarkers of renal dysfunction, endothelial dysfunction, and inflammation were associated with incident HFrEF. By contrast, only natriuretic peptides and UACR were associated with HFpEF. These findings highlight the need for future studies focused on identifying novel biomarkers of the risk of HFpEF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamacardio.2017.4987

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 260

Metadata

Authors
de Boer, R. A., Nayor, M., deFilippi, C. R., Enserro, D., Bhambhani, V., Kizer, J. R., Blaha, M. J., Brouwers, F. P., Cushman, M., Lima, J. A. C., Bahrami, H., van der Harst, P., Wang, T. J., Gansevoort, R. T., Fox, C. S., Gaggin, H. K., Kop, W. J., Liu, K., Vasan, R. S., Psaty, B. M., Lee, D. S., Hillege, H. L., Bartz, T. M., Benjamin, E. J., Chan, C., Allison, M., Gardin, J. M., Januzzi, J. L., Shah, S. J., Levy, D., Herrington, D. M., Larson, M. G., van Gilst, W. H., Gottdiener, J. S., Bertoni, A. G., & Ho, J. E.
Venue
JAMA Cardiology
Published
2018-03-01
Volume
3
Issue
3
Pages
215
ISSN
2380-6583 (ISSN-L)
OpenAlex
W2783147489
Cited by
260
References
45
FWCI
19.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction. https://app.cochat.ai/papers/10.1001/jamacardio.2017.4987
The paper
de Boer, R. A., Nayor, M., deFilippi, C. R., Enserro, D., Bhambhani, V., Kizer, J. R., Blaha, M. J., Brouwers, F. P., Cushman, M., Lima, J. A. C., Bahrami, H., van der Harst, P., Wang, T. J., Gansevoort, R. T., Fox, C. S., Gaggin, H. K., Kop, W. J., Liu, K., Vasan, R. S., . . . Ho, J. E. (2018). Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction. JAMA Cardiology. https://doi.org/10.1001/jamacardio.2017.4987

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.